ATR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ATR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The 3-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past three years. As of today (2025-06-26), AptarGroup's 3-Year Sharpe Ratio is 0.65.
For the Medical Instruments & Supplies subindustry, AptarGroup's 3-Year Sharpe Ratio, along with its competitors' market caps and 3-Year Sharpe Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, AptarGroup's 3-Year Sharpe Ratio distribution charts can be found below:
* The bar in red indicates where AptarGroup's 3-Year Sharpe Ratio falls into.
The 3-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset in the last three years. A stock / portfolio's 3-Year Sharpe Ratio can be calculated by dividing the difference between the three-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the investment returns over the past three years.
AptarGroup (NYSE:ATR) 3-Year Sharpe Ratio Explanation
The 3-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past three years. It is calculated as the annualized result of the average three-year monthly excess returns divided by its standard deviation in the three-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.
The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.
Thank you for viewing the detailed overview of AptarGroup's 3-Year Sharpe Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Xiangwei Gong | officer: President, Asia | 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60010 |
Marc Prieur | officer: Segment President | 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014 |
Hedi Tlili | officer: Segment President | 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014 |
Shiela Vinczeller | officer: Chief Human Resource Officer | 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014 |
Stephan B. Tanda | director, officer: President and CEO | C/O PATHEON N.V., HERENGRACHT 483, AMSTERDAM P7 1017 BT |
Monnas Giovanna Kampouri | director | C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014 |
Kimberly Chainey | officer: EVP and General Counsel | 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014 |
Gael Touya | officer: Segment President | 475 W. TERRA COTTA AVE., SUITE E, CRYSTAL LAKE IL 60014 |
Robert Kuhn | officer: EVP & CFO | C/O APTARGROUP 475 W. TERRA COTTA AVENUE, SUITE E, CRYSTAL LAKE IL 60014 |
Sarah Js Glickman | director | 60 BINNEY STREET, C/O BLUEBIRD BIO, INC., CAMBRIDGE MA 02142 |
George L Fotiades | director | 281 SUMMIT AVENUE, SUMMIT NJ 07901 |
Julie Xing | director | 265 EXCHANGE DRIVE, SUITE 301, CRYSTAL LAKE IL 60014 |
Maritza Gomez Montiel | director | C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014 |
Matthew L. Trerotola | director | 2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON DE 19808 |
Ralf K. Wunderlich | director | C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014 |
From GuruFocus
By GuruFocus News • 04-15-2025
By GuruFocus News • 05-02-2025
By GuruFocus News • 02-08-2025
By GuruFocus News • 05-19-2025
By GuruFocus News • 04-14-2025
By GuruFocus News • 05-03-2025
By GuruFocus News • 05-09-2025
By Business Wire • 04-16-2025
By GuruFocus News • 05-01-2025
By GuruFocus News • 05-21-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.